Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Cantor Fitzgerald
Healthtrust
Accenture
Dow
Johnson and Johnson
Cipla
Express Scripts
US Department of Justice

Generated: May 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020490

« Back to Dashboard

NDA 020490 describes ALPHAGAN, which is a drug marketed by Allergan and is included in four NDAs. There are seven patents protecting this drug and two Paragraph IV challenges. Additional details are available on the ALPHAGAN profile page.

The generic ingredient in ALPHAGAN is brimonidine tartrate. There are eleven drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the brimonidine tartrate profile page.
Summary for 020490
Tradename:ALPHAGAN
Applicant:Allergan
Ingredient:brimonidine tartrate
Patents:0
Therapeutic Class:Ophthalmic Agents
Medical Subject Heading (MeSH) Categories for 020490

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:SOLUTION/DROPS;OPHTHALMICStrength0.5%
Approval Date:Mar 13, 1997TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Queensland Health
Dow
McKesson
Daiichi Sankyo
Express Scripts
Citi
Colorcon
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.